The Challenge of Return to Work after Breast Cancer: The Role of Family Situation, CANTO Cohort

Published on Oct 1, 2021in Current Oncology3.677
· DOI :10.3390/CURRONCOL28050330
Elsa Caumette , Ines Vaz-Luis18
Estimated H-index: 18
+ 12 AuthorsPaul Cottu34
Estimated H-index: 34
Sources
Abstract
Return to work (RTW) after breast cancer is associated with improved quality of life. The link between household characteristics and RTW remains largely unknown. The aim of this study was to examine the effect of the family situation on women’s RTW two years after breast cancer. We used data of a French prospective cohort of women diagnosed with stage I-III, primary breast cancer (CANTO, NCT01993498). Among women employed at diagnosis and under 57 years old, we assessed the association between household characteristics (living with a partner, marital status, number and age of economically dependent children, support by the partner) and RTW. Logistic regression models were adjusted for age, household income, stage, comorbidities, treatments and their side effects. Analyzes stratified by age and household income were performed to assess the association between household characteristics and RTW in specific subgroups. Among the 3004 patients included, women living with a partner returned less to work (OR = 0.63 [0.47–0.86]) and decreased their working time after RTW. Among the 2305 women living with a partner, being married was associated with decreased RTW among women aged over 50 (OR = 0.57 [0.34–0.95]). Having three or more children (vs. none) was associated with lower RTW among women with low household income (OR = 0.28 [0.10–0.80]). Household characteristics should be considered in addition to clinical information to identify vulnerable women, reduce the social consequence of cancer and improve their quality of life.
References33
Newest
#1Bertrand Porro (University of Angers)H-Index: 3
#2Marie-José Durand (Université de Sherbrooke)H-Index: 24
Last. Yves Roquelaure (University of Angers)H-Index: 35
view all 5 authors...
PURPOSE To propose a conceptual framework of the return to work (RTW) of breast cancer survivors (BCS) according to the transactional perspective. METHODS The Technique for Research of Information by Animation of a Group of Experts was implemented. For each determinant in an initial list established from the literature, experts selected for the consensus exercise were firstly asked to indicate their agreement level individually, via an online questionnaire. Determinants obtaining an agreement le...
Source
#1Hyuna Sung (ACS: American Cancer Society)H-Index: 19
#2Jacques Ferlay (IARC: International Agency for Research on Cancer)H-Index: 72
Last. Freddie Bray (IARC: International Agency for Research on Cancer)H-Index: 126
view all 7 authors...
This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer. Worldwide, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated ...
Source
#1Phyllis Butow (USYD: University of Sydney)H-Index: 113
#2Rebekah Laidsaar-Powell (USYD: University of Sydney)H-Index: 13
Last. Bogda Koczwara (Flinders Medical Centre)H-Index: 28
view all 5 authors...
Purpose Returning to work (RTW) after cancer treatment can be challenging, but when desired, has many benefits. While there are many qualitative studies (reviews and recent studies) available on cancer survivors’ experience of returning to work, synthesis of these qualitative studies is lacking. We aimed to summarise the existing qualitative reviews and recent studies following the last published review, to examine cancer survivors’ motivations for and experiences of RTW, and to highlight factor...
Source
#1Angela G. E. M. de Boer (PHRI: Public Health Research Institute)H-Index: 15
#2Steffen TorpH-Index: 16
Last. Linda Sharp (Newcastle University)H-Index: 48
view all 9 authors...
Almost half of people diagnosed with cancer are working age. Survivors have increased risk of unemployment, but little is known about long-term work retention. This systematic review and meta-analysis assessed work retention and associated factors in long-term cancer survivors. We searched Medline/Pubmed, Embase, PsychINFO, and CINAHL for studies published 01/01/2000–08/01/2019 reporting work retention in adult cancer survivors ≥ 2 years post-diagnosis. Survivors had to be in paid work at diagno...
Source
#1Agnès Dumas (NIH: National Institutes of Health)H-Index: 9
#2Ines Maria Vaz Duarte Luis (French Institute of Health and Medical Research)H-Index: 5
Last. Gwenn Menvielle (University of Paris)H-Index: 3
view all 21 authors...
PURPOSEAdverse effects of breast cancer treatment can negatively affect survivors’ work ability. Previous reports lacked detailed clinical data or health-related patient-reported outcomes (PROs) an...
Source
Circulating microRNA (ct-miRNAs) are able to identify patients with differential response to HER2-targeted therapy. However, their dynamics are largely unknown. We assessed 752 miRNAs from 52 NeoALTTO patients with plasma pairs prior and two weeks after trastuzumab. Increased levels of ct-miR-148a-3p and ct-miR-374a-5p were significantly associated with pathological complete response (pCR) (p = 0.008 and 0.048, respectively). At a threshold ≥ the upper limit of the 95%CI of the mean difference, ...
Source
#1Martina E. Schmidt (DKFZ: German Cancer Research Center)H-Index: 25
#2Sophie Scherer (DKFZ: German Cancer Research Center)H-Index: 1
Last. Karen Steindorf (DKFZ: German Cancer Research Center)H-Index: 37
view all 4 authors...
: For breast cancer survivors return to work (RTW) is important from an economic, societal and personal perspective. Thus, we investigated the impact of side effects and other factors on RTW. Five years post-diagnosis 135 disease-free breast cancer survivors below retirement age who were employed pre-diagnosis recorded their current and previous working status and reasons for impaired RTW. Patient-reported outcomes were prospectively reported over the cancer continuum. One year post-surgery 57% ...
Source
#1Christian Heuser (University Hospital Bonn)H-Index: 4
#2Sarah Halbach (University Hospital Bonn)H-Index: 9
Last. Nicole Ernstmann (University Hospital Bonn)H-Index: 24
view all 6 authors...
Return to work (RTW) is a key parameter of outcome quality that ensures social participation. Therefore, this study analyses the sociodemographic and disease-related determinants of RTW among newly diagnosed breast cancer patients. In a prospective, multicentre cohort study, breast cancer patients were surveyed three times: directly after surgery, after 10 weeks, and after 40 weeks. Logistic regression analysis was applied to estimate the association of RTW at 40 weeks following discharge with s...
Source
Last. Max S. ManoH-Index: 16
view all 10 authors...
BACKGROUND: In North America and Europe, return-to-work (RTW) rates vary among breast cancer (BC) survivors, from 24% to 66% and from 53% to 82% at 6 and 36 months after diagnosis, respectively. To date, there is a lack of data on RTW rates after BC diagnosis in Latin America. Therefore, the primary objectives of this study were to define RTW rates at 12 and 24 months after BC diagnosis and to identify the factors associated with RTW in this population. METHODS: In total, 125 employed women from...
Source
#1Freddie Bray (IARC: International Agency for Research on Cancer)H-Index: 126
#2Jacques Ferlay (IARC: International Agency for Research on Cancer)H-Index: 72
Last. Ahmedin Jemal (ACS: American Cancer Society)H-Index: 139
view all 6 authors...
This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. In both sexes combined, lung cancer...
Source
Cited By0
Newest
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.